Skip to main content
. 2019 Jan 31;9(4):819–831. doi: 10.1016/j.apsb.2019.01.018

Figure 3.

Fig. 3

(A) CRT exposure on the cell surface of 4T1 cells was evaluated by flow cytometry after different treatments. (B) Immunofluorescence microscopy of CRT expression on the cell surface of 4T1 cells after different treatments. The scale bar represents 10 μm. (C) and (D) DOX and IMQ plasma concentration–time profiles in BALB/c mice treated with different DOX and IMQ formulations (at a dose of 3 mg/kg DOX, 0.75 mg/kg IMQ; data are mean ± SD, n = 3).

HHS Vulnerability Disclosure